Recruiting COVID-19 Studies in Cleveland
NE3107 in Adults With Neurological Symptoms of Long COVID
Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in ...
A Study of Baricitinib (LY3009104) in Children With COVID-19
The purpose for this study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID -19) and to confirm the dose....
About COVID-19 Clinical Trials in Cleveland
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus that primarily affects the respiratory system. Long COVID (PASC) involves persistent symptoms weeks or months after initial infection. Treatment includes antiviral medications, monoclonal antibodies, and supportive care.
There are currently 2 covid-19 clinical trials recruiting participants in Cleveland, OHIO. These studies are seeking a combined 232 participants. Research is being sponsored by BioVie Inc., Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
COVID-19 Clinical Trials in Cleveland — FAQ
Are there covid-19 clinical trials in Cleveland?
Yes, there are 2 covid-19 clinical trials currently recruiting in Cleveland, OHIO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Cleveland?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cleveland research site will contact you about next steps.
Are clinical trials in Cleveland free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cleveland studies also compensate for your time and travel.
What covid-19 treatments are being tested?
The 2 active trials in Cleveland are testing new therapies including novel drugs, biologics, and treatment approaches for covid-19.
Data updated March 2, 2026 from ClinicalTrials.gov